치은농양 치료제 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)

The future of the global gum abscess medicine market looks promising with opportunities in the hospital and pharmacy markets. The global gum abscess medicine market is expected to grow with a CAGR of 6.2% from 2025 to 2031. The major drivers for this market are the increasing prevalence of periodontal diseases, the growing awareness towards oral health, and ongoing advancement in treatment options.

• Lucintel forecasts that, within the type category, minocycline is expected to witness the highest growth over the forecast period.
• Within the application category, pharmacy is expected to witness higher growth due to its widespread presence in retail and online.
• In terms of region, North America is expected to witness the highest growth over the forecast period due to the strong presence of pharmaceutical and healthcare companies in the region.

Emerging Trends in the Gum Abscess Medicine Market

The gum abscess medicine market is witnessing various emerging trends, driven by advancements in treatment options, increasing awareness of oral health, and greater adoption of integrated care models. The shift toward more effective, affordable, and accessible treatment options is shaping the future of the market. These trends include innovations in treatment approaches, greater use of telehealth services for dental care, and expanding access to preventive dental products. Below are five key emerging trends that are transforming the gum abscess medicine market.

• Shift toward Minimally Invasive Treatments: Minimally invasive treatments, such as laser therapy and non-surgical drainage of abscesses, are becoming increasingly popular in the gum abscess medicine market. These treatments offer patients quicker recovery times, less pain, and fewer complications compared to traditional methods. As technology advances, dental professionals are able to offer more precise treatments that are less intrusive, reducing the need for more extensive surgery. This trend is driving the adoption of innovative technologies in dental care and improving patient satisfaction with less invasive treatments.
• Growing Use of Antibiotics and Topical Treatments: Antibiotic therapy remains a cornerstone in treating gum abscesses. However, there is a growing trend towards the use of topical antibiotic treatments, such as gels, mouthwashes, and ointments, which are becoming more effective in managing localized infections. The increasing awareness of antibiotic resistance has also prompted the development of new antibiotic formulations to treat resistant strains of bacteria. This shift is expected to drive growth in the market as patients and healthcare providers increasingly prefer easy-to-use topical treatments in conjunction with oral antibiotics for enhanced therapeutic outcomes.
• Advancements in Diagnostic Technologies: Early diagnosis of gum abscesses is critical to effective treatment. The adoption of advanced diagnostic tools such as dental imaging, 3D scanning, and real-time diagnostic technologies is on the rise. These tools allow dental professionals to detect abscesses at earlier stages, even before symptoms appear. This trend is leading to more personalized treatment plans and better outcomes for patients. Additionally, the integration of artificial intelligence in diagnostic technologies could further enhance the precision of detecting gum infections, driving growth in the market for diagnostic tools and treatments.
• Focus on Preventive Oral Care: Preventive care is gaining increasing attention as a means to reduce the occurrence of gum abscesses. With a growing focus on oral hygiene education and preventive care products such as antibacterial mouthwashes, toothpastes, and floss, the incidence of gum infections can be significantly reduced. Many healthcare providers and insurance companies are now offering coverage for preventive dental services, which is encouraging patients to seek regular dental check-ups. This trend is helping to reduce the long-term need for more aggressive treatments, while expanding the market for preventive oral care products.
• Integration of Telehealth in Dental Care: Telehealth is an emerging trend in dental care that allows patients to consult with dental professionals remotely for early treatment advice. The rise of telemedicine platforms for consultations, diagnosis, and follow-ups for gum abscesses is particularly beneficial for patients in rural areas with limited access to dental care. This shift towards digital health services is increasing access to care and enabling faster intervention, especially for patients who may have difficulty accessing in-person care. The integration of telehealth is expected to further boost the demand for gum abscess medicine as it makes treatment more accessible.

These emerging trends in the gum abscess medicine market-such as the shift toward minimally invasive treatments, growing use of antibiotics and topical treatments, advancements in diagnostic technologies, focus on preventive care, and the integration of telehealth-are reshaping the market by improving treatment outcomes and patient access to care. These trends are expected to drive the growth of the market by enhancing the effectiveness, affordability, and accessibility of gum abscess treatments worldwide.

Recent Developments in the Gum Abscess Medicine Market

Recent developments in the global gum abscess medicine market have been driven by innovations in treatment options, enhanced awareness of oral health, and advancements in dental technologies. As demand for effective treatments increases, there have been several notable advancements in both pharmaceutical and non-pharmaceutical treatments. This section highlights key developments across different sectors of the market.

• Increased Adoption of Laser Therapy: Laser therapy has gained traction as a less invasive and more efficient treatment for gum abscesses. Recent advancements in laser technology have allowed for precise treatments that minimize damage to surrounding tissues while promoting faster healing. Laser therapy has shown promising results in reducing pain and recovery times for patients, making it a popular choice for dental professionals. As more research supports its efficacy, laser therapy is expected to become more widely available, contributing to the overall growth of the gum abscess medicine market.
• Introduction of New Antibiotic Formulations: The development of new antibiotic formulations specifically targeting the bacteria responsible for gum abscesses is a significant recent development. As antibiotic resistance continues to be a growing concern, pharmaceutical companies are focusing on developing more effective antibiotics to treat resistant strains. These new formulations are expected to provide better outcomes for patients, particularly in regions with high rates of drug-resistant infections. This will likely drive the growth of the gum abscess medicine market as healthcare providers seek more effective treatment options.
• Growing Market for Over-the-Counter (OTC) Treatments: There has been a significant rise in the availability and demand for over-the-counter (OTC) treatments for gum abscesses, including antiseptic mouthwashes, gels, and pain relief products. These products offer patients an easy way to manage gum infections at home, reducing the need for immediate dental intervention in mild cases. As the market for OTC dental products expands, manufacturers are focusing on improving product formulations to enhance efficacy and patient satisfaction. This trend is helping to make gum abscess treatments more accessible and affordable.
• Rising Focus on Preventive Care Initiatives: Healthcare initiatives promoting preventive care for oral health have led to a reduction in the incidence of gum abscesses in some regions. Government-backed campaigns and public health efforts focused on improving oral hygiene practices have contributed to a growing awareness of the importance of early intervention and prevention. As a result, fewer people are developing severe gum infections that require intensive medical treatment. This trend is shifting the focus from reactive to proactive care in the gum abscess medicine market.
• Expansion of Dental Services in Rural Areas: The expansion of dental care services in rural areas, particularly in developing countries, has been another key development in the gum abscess medicine market. Improved access to dental care, coupled with mobile dental clinics and government initiatives, is allowing people in remote regions to receive timely treatment for gum abscesses. As healthcare infrastructure continues to grow in these areas, more patients will have access to both preventive and therapeutic care for gum infections, expanding the overall market for gum abscess medicine.

These recent developments in the gum abscess medicine market-including the rise of laser therapy, the introduction of new antibiotics, increased OTC treatment options, a focus on preventive care, and expanded access to dental services-are positively impacting the market. As the demand for effective, accessible, and affordable treatments grows, these advancements will continue to drive the evolution of the market, improving outcomes for patients and promoting better oral health globally.

Strategic Growth Opportunities in the Gum Abscess Medicine Market

The global gum abscess medicine market is witnessing growth opportunities driven by advancements in treatment modalities, increasing awareness of oral health, and improving healthcare infrastructure. With rising incidences of gum diseases and the demand for effective, accessible treatments, there are key applications within the market that present strong growth potential. These opportunities are centered on enhancing treatment options, improving patient access, and promoting preventive care, which together could reshape the future of gum abscess medicine.

• Minimally Invasive Treatment Technologies: Minimally invasive techniques, such as laser therapy and laser-assisted drainage, offer a significant growth opportunity in the gum abscess medicine market. These treatments allow for quicker recovery times, reduced pain, and lower risks of complications compared to traditional surgical methods. As these technologies become more widely available and affordable, they are expected to drive demand for effective and less invasive treatment options. The market could see an increase in the adoption of these methods in dental clinics, particularly in developed countries where patients prefer less invasive procedures with quicker healing times.
• Over-the-Counter (OTC) Treatments: There is a growing demand for over-the-counter (OTC) treatments such as antiseptic mouthwashes, gels, and topical antibiotics for managing gum abscesses. OTC products provide accessible, cost-effective treatment options for patients experiencing mild gum infections. The ease of access to these products encourages early intervention, reducing the need for more invasive treatments. With rising awareness of oral health, OTC gum abscess medicines have the potential to become a significant portion of the market, particularly in regions with high levels of self-care practices and where access to dental professionals may be limited.
• Focus on Preventive Oral Care Products: Preventive oral care products, such as antibacterial toothpastes, mouthwashes, and floss, present a major growth opportunity in reducing the incidence of gum abscesses. As more people adopt regular preventive care routines, the need for invasive treatments diminishes, contributing to market growth. Additionally, public health campaigns and dental care education programs are promoting the importance of maintaining oral hygiene to prevent infections. This trend is expected to grow, leading to an increase in preventive product sales, particularly in markets with high awareness about gum diseases and the importance of maintaining overall oral health.
• Expansion of Telehealth in Dentistry: Telehealth services are gaining popularity in the dental care sector, offering remote consultations, diagnoses, and follow-up treatments for gum abscesses. This is particularly beneficial in rural or underserved regions where access to dental professionals is limited. The growth of telehealth platforms enables patients to seek professional advice quickly, leading to early diagnosis and timely treatment of gum infections. This will expand access to treatment and increase the adoption of gum abscess medicine globally, especially in emerging markets where there is increasing internet access and digital literacy.
• Advances in Antibiotic Development: The development of more effective and targeted antibiotics for treating gum abscesses represents a significant opportunity in the global gum abscess medicine market. With rising concerns about antibiotic resistance, pharmaceutical companies are focusing on creating new antibiotics that target the specific bacteria causing gum infections. Additionally, combination therapies that include both antibiotics and anti-inflammatory agents can improve treatment outcomes. As these antibiotics enter the market, they could become a preferred choice for dentists and patients, driving growth in the pharmaceutical segment of the gum abscess medicine market.

These strategic growth opportunities-minimally invasive treatments, OTC solutions, preventive care products, telehealth adoption, and advancements in antibiotic development-are transforming the global gum abscess medicine market. Together, they improve treatment accessibility, reduce costs, and enhance the overall quality of care. These trends are likely to drive further market growth, particularly in regions with emerging healthcare infrastructure, while also contributing to better oral health outcomes worldwide.

Gum Abscess Medicine Market Driver and Challenges

The global gum abscess medicine market is influenced by a variety of drivers and challenges stemming from technological, economic, and regulatory factors. Key drivers include the rise in gum infections, advances in medical technologies, and increasing awareness of oral health, while challenges involve issues related to antibiotic resistance, healthcare access, and regulatory hurdles. Understanding these factors helps to highlight both the potential for growth and the obstacles that may hinder market progress.

The factors responsible for driving the gum abscess medicine market include:

1. Increasing Incidence of Gum Diseases: The rising prevalence of gum diseases, driven by factors such as poor oral hygiene, smoking, and an aging population, is a major driver of the gum abscess medicine market. As the incidence of gum abscesses increases, more patients require timely and effective treatments, leading to higher demand for gum abscess medicine. Additionally, higher awareness of the connection between gum health and overall health has prompted more people to seek treatment for gum infections, thus contributing to market growth.

2. Advances in Treatment Technologies: The development of new, less invasive treatment options for gum abscesses is driving market growth. Technologies like laser therapy and non-surgical drainage techniques are becoming more prevalent, allowing for quicker recovery times and fewer complications compared to traditional methods. These technological advancements improve patient outcomes and reduce the cost of treatment, making gum abscess treatment more accessible and efficient, which is contributing to market expansion.

3. Growing Consumer Awareness and Preventive Care: There is a growing global emphasis on preventive dental care, which is reducing the incidence of gum abscesses and contributing to the market's expansion. Consumers are increasingly aware of the importance of maintaining oral hygiene to avoid infections, prompting higher demand for preventive oral care products such as mouthwashes and specialized toothpaste. Preventive care education campaigns are likely to reduce the long-term need for treatment while expanding the market for preventive products.

4. Availability of Affordable Over-the-Counter (OTC) Solutions: The growing availability of affordable, effective OTC products for treating gum abscesses is increasing access to care and driving market growth. OTC treatments such as antiseptic mouthwashes, gels, and topical antibiotics are popular among consumers due to their convenience and cost-effectiveness. These products allow patients to address minor gum infections at home, leading to earlier treatment and reduced burden on dental clinics, which in turn supports the growth of the gum abscess medicine market.

5. Growing Digital Health and Telemedicine Platforms: The rise of telehealth services in dental care, especially during the COVID-19 pandemic, has increased the accessibility of consultations for gum abscesses. Digital health platforms allow patients to remotely consult dental professionals, receive guidance on treatment options, and monitor progress. This increased accessibility, particularly in underserved or rural areas, expands the reach of gum abscess medicines, driving growth in the market.

Challenges in the gum abscess medicine market are:

1. Antibiotic Resistance: Antibiotic resistance is a growing concern in the treatment of gum abscesses. The overuse or misuse of antibiotics can lead to the development of resistant strains of bacteria, making treatment more difficult. This challenge is pushing the pharmaceutical industry to develop new, more targeted antibiotics, but it remains a significant hurdle in managing gum infections effectively. As resistance increases, the market faces the challenge of maintaining effective treatment options.

2. Limited Access to Dental Care in Rural Areas: While urban areas benefit from advanced dental care options, access to dental services remains limited in rural regions, especially in developing countries. This lack of access to dental professionals and treatments means that gum abscesses often go undiagnosed or untreated until they become severe. This limitation creates an obstacle for market growth, as it prevents a large segment of the population from benefiting from timely interventions and effective treatments.

3. Regulatory and Reimbursement Issues: The regulatory landscape for dental medicines can be complex, with different standards and requirements in different regions. Navigating these regulations can delay the availability of new treatments and increase costs for manufacturers. Additionally, reimbursement policies for dental treatments vary by country, which can affect market adoption, especially in countries with stricter healthcare reimbursement policies or limited insurance coverage for dental services.

The drivers and challenges impacting the gum abscess medicine market-such as increasing gum disease prevalence, technological advancements, and greater consumer awareness-present both opportunities and obstacles. However, issues like antibiotic resistance, limited access to dental care, and regulatory hurdles must be addressed to ensure continued market growth. By focusing on overcoming these challenges, the market can continue to expand, providing patients with more effective, accessible, and affordable treatments for gum abscesses.

List of Gum Abscess Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gum abscess medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gum abscess medicine companies profiled in this report include-

• OraPharma
• Sunstar Group
• Hainan Jianke Pharmaceutical
• Shenzhen Nanyue Pharmaceutical
• Jiangsu Chen Brand Bond Pharmaceutical

Gum Abscess Medicine Market by Segment

The study includes a forecast for the global gum abscess medicine market by type, application, and region.

Gum Abscess Medicine Market by Type [Value from 2019 to 2031]:

• Minocycline
• Chlorhexidine
• Iodine Glycerin

Gum Abscess Medicine Market by Application [Value from 2019 to 2031]:

• Hospital
• Pharmacy
• Others

Gum Abscess Medicine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Gum Abscess Medicine Market

The global gum abscess medicine market has seen significant developments in recent years, driven by advances in treatments, increasing awareness of oral health, and rising demand for effective therapies for gum diseases. Gum abscesses, often caused by bacterial infections, can lead to severe complications if not treated promptly. This has spurred research and innovation in the medical field to develop more effective and accessible treatments for managing gum abscesses. The market is particularly influenced by trends in pharmaceuticals, healthcare access, and dental technologies across various countries.

• United States: In the U.S., the gum abscess medicine market is evolving with a focus on antibiotic therapies and advanced dental procedures. Recent developments include the increasing use of minimally invasive treatments, such as laser therapy, to treat gum abscesses. Moreover, the availability of over-the-counter antiseptic mouthwashes and topical treatments for gum infections has been growing. U.S. healthcare systems are also adopting integrated dental care approaches, promoting early diagnosis and treatment. Additionally, there is a shift toward combining antibiotic therapies with pain management to enhance treatment outcomes, especially in patients with recurring infections.
• China: The Chinese gum abscess medicine market has been expanding rapidly, driven by an increasing awareness of oral hygiene and improving healthcare access. The introduction of affordable treatment options, including antibiotics and topical gels, has helped expand the market. Traditional Chinese Medicine (TCM) has also gained popularity, with herbal remedies being used alongside conventional medical treatments. The Chinese government's increased focus on public health and dental care initiatives is helping improve awareness and accessibility to treatments for gum abscesses. Additionally, urbanization and higher disposable incomes are making advanced treatments more accessible to a larger segment of the population.
• Germany: The German dental care market is highly developed, and the treatment of gum abscesses has benefited from innovations in both medical and technological fields. Recent developments include the adoption of more sophisticated diagnostic tools such as dental imaging systems, which aid in the early detection of gum infections. Moreover, the use of laser therapy and antibiotic treatments has become more prevalent, allowing for more effective and less invasive interventions. German healthcare policies are also emphasizing preventive oral care, which is reducing the incidence of gum abscesses and promoting overall oral health among the population.
• India: In India, the gum abscess medicine market is growing due to increased urbanization, rising disposable incomes, and better awareness of oral health. The market is seeing the expansion of both pharmaceutical treatments, including antibiotics and antiseptic mouthwashes, and Ayurvedic-based remedies. The government's focus on expanding healthcare access, especially in rural areas, is also contributing to market growth. With an increase in oral health education campaigns, patients are seeking timely treatment for gum abscesses, resulting in a growing demand for both over-the-counter and prescription-based solutions. The market is also witnessing a shift toward preventive dental care.
• Japan: Japan has been a leader in adopting innovative dental technologies, and the gum abscess medicine market in the country is no exception. The introduction of advanced treatments such as laser therapy and minimally invasive surgical options has gained traction. Additionally, there is a growing preference for antibiotics and antiseptic gels for the initial treatment of gum abscesses. Japan's aging population is contributing to an increase in demand for dental care, including treatments for gum infections. The Japanese government have been promoting preventive oral care through public health initiatives, which has resulted in lower rates of gum abscesses in the country.

Features of the Global Gum Abscess Medicine Market

• Market Size Estimates: Gum abscess medicine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Gum abscess medicine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Gum abscess medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the gum abscess medicine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gum abscess medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the gum abscess medicine market by type (minocycline, chlorhexidine, and iodine glycerin), application (hospital, pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Gum Abscess Medicine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Minocycline: Trends and Forecast (2019-2031)
• 4.4 Chlorhexidine: Trends and Forecast (2019-2031)
• 4.5 Iodine Glycerin: Trends and Forecast (2019-2031)

5. Global Gum Abscess Medicine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Pharmacy: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Gum Abscess Medicine Market by Region

7. North American Gum Abscess Medicine Market

• 7.1 Overview
• 7.2 North American Gum Abscess Medicine Market by Type
• 7.3 North American Gum Abscess Medicine Market by Application
• 7.4 United States Gum Abscess Medicine Market
• 7.5 Mexican Gum Abscess Medicine Market
• 7.6 Canadian Gum Abscess Medicine Market

8. European Gum Abscess Medicine Market

• 8.1 Overview
• 8.2 European Gum Abscess Medicine Market by Type
• 8.3 European Gum Abscess Medicine Market by Application
• 8.4 German Gum Abscess Medicine Market
• 8.5 French Gum Abscess Medicine Market
• 8.6 Spanish Gum Abscess Medicine Market
• 8.7 Italian Gum Abscess Medicine Market
• 8.8 United Kingdom Gum Abscess Medicine Market

9. APAC Gum Abscess Medicine Market

• 9.1 Overview
• 9.2 APAC Gum Abscess Medicine Market by Type
• 9.3 APAC Gum Abscess Medicine Market by Application
• 9.4 Japanese Gum Abscess Medicine Market
• 9.5 Indian Gum Abscess Medicine Market
• 9.6 Chinese Gum Abscess Medicine Market
• 9.7 South Korean Gum Abscess Medicine Market
• 9.8 Indonesian Gum Abscess Medicine Market

10. ROW Gum Abscess Medicine Market

• 10.1 Overview
• 10.2 ROW Gum Abscess Medicine Market by Type
• 10.3 ROW Gum Abscess Medicine Market by Application
• 10.4 Middle Eastern Gum Abscess Medicine Market
• 10.5 South American Gum Abscess Medicine Market
• 10.6 African Gum Abscess Medicine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Gum Abscess Medicine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 OraPharma
  • Company Overview
  • Gum Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Sunstar Group
  • Company Overview
  • Gum Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Hainan Jianke Pharmaceutical
  • Company Overview
  • Gum Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Shenzhen Nanyue Pharmaceutical
  • Company Overview
  • Gum Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Jiangsu Chen Brand Bond Pharmaceutical
  • Company Overview
  • Gum Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us